Workflow of peptide-radionuclide conjugates at PepLib
Process One—Target Selection
Process Two—Peptide Screening
·PRC-peptide screening & design:DRP-PD + AI + mRNA Display + Med-chem
·Advantages of PepLib’s DRP-PD Library
·PepLib’s AI Platform–3 modules
·Med-chem optimization: from hits to leads (2-4 months)
Process Three—In-vitro Study for PRC development
PepLib’s Med-chem Capability
Process Four—In-vivo Study for PRC development
·Advantages of in-vivo PRC Platform
Process Five—IIT Study
*Proven execution: higher productivity & faster speed
·We can conduct independent experiments throughout the entire process internally, except for the IIT study.
·For the IIT study, we deeply collaborate with hospitals in China.
Empowering the thriving development of peptide therapeutics worldwide, enabling cost‑effective access to peptide medicines for patients around the globe, and contributing to human health.
Hunan Zhongsheng Quanpeptide Biotechnology Co., Ltd.
Contact Information
Email:info@peplib.com
Company Address: Building 5, Modern Service Industry Headquarters Park, No. 1769 Yunlong Avenue, Yunlong Demonstration Zone, Zhuzhou, Hunan Province
Copyright © 2023 Hunan Zhongsheng Quanpeptide Biotechnology Co., Ltd. This website supports IPv6.